ME/CFS & Fibromyalgia Around the Web

1165442_www_2

Is It All In My Head?

In the mid 1980s, Carole Howard was a highly driven academic, simultaneously pursuing a master’s degree from Loyola University in Chicago and serving as a college administrator—until the fateful morning when she got out of bed feeling not quite herself. “I woke up one day in a lot of pain,” Howard recalls. “I thought I had the flu.”

Psychology Today

Helping hand on housing ladder

Adrienne, who suffers from Congenital Laxity and Fibromyalgia, which means she has mobility problems and chronic fatigue, said: “I have difficulty getting up and down stairs because of my conditions so my only options were a ground floor flat or a bungalow. I wanted a bungalow rather than a flat as I wanted somewhere I could settle long-term but the majority of shared ownership schemes tend to be flats.

24dash.com

Wharf to Wharf 2009: After 35 years, Cynthia Wagner’s ready to run again

It may be the same popular event, but now at the age of 64, it’s a new Cynthia Wagner who will take on the 6-mile Wharf to Wharf race this year. Since Wagner first approached the starting line in 1974, she has had to overcome many challenges, ranging from the stress of single motherhood to health issues. Now, after 35 years, she is back for another race.

Santa Cruz Sentinel

Advances in Chronic Pain Management

Advances in Chronic Pain Management brings together leading experts in the fields of pain management, anaesthesia and neurology to discuss the central issues and current challenges involved in the management of patients with chronic pain.

Nature Network

Milnacipran (Savella) for fibromyalgia: What makes it different?

Milnacipran, marketed under the brand name Savella in the United States, is the latest drug to receive Food and Drug Administration (FDA) approval for the management of fibromyalgia. The FDA approved fibromyalgia indications for two other drugs — pregabalin (Lyrica) and duloxetine (Cymbalta) — in 2007 and 2008, respectively.

Mayo Clinic

Understanding Fibromyalgia: Lessons from the Broader Pain Research Community

Fibromyalgia (FM) is a chronic pain condition marked by centrally mediated augmentation of pain and sensory processes. Skepticism has marked the history of this condition, but more recent study has identified neurobiological underpinnings supporting many of the symptoms associated with this condition. Early research in FM had unprecedented latitude within the rheumatology community to borrow heavily from theory and methods being applied in chronic pain research more generally.

The Journal of Pain

Living with Fibromyalgia

The first thing you need to know about Fibromyalgia is that there is no cure, but you can rest assure it is not terminal. Fibromyalgia is not a disease it is more of a condition that affects soft tissues, i.e. muscle, tendons and other soft tissues. This condition is diagnosed by your physician by process of elimination and it could take months even years before having been properly diagnosed. The symptoms can imitate various other muscular diseases so that is why you must be properly diagnosed.

Associated Content/JMR

If you liked this article, please share.
Share on Facebook0Tweet about this on TwitterShare on Google+0Share on StumbleUpon0Email this to someone

Join the Discussion.

We'd love to hear from you - leave a comment below

*